More on KALV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+58.7% Growth)
- Ratings (5.8 Score)

Upcoming Events

- Earnings (9/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

KalVista Pharmaceuticals (NQ:KALV)
Delayed: 26.95 +0.01 (0.04%)
Prev. Close $26.94  
Open$26.95 
52 Wk High$ 
52 Wk Low$ 
Day High$26.96 
Day Low$26.94 
P/E N/A  
EPS$ 
Volume6,431,873 

Friends, Peers and Foes (?): MGX, ARGX, OCUL, VRTX, ACOG (more...)

Jun 1, 2026 09:06 AM Form SC TO-T/A KalVista Pharmaceuticals Filed by: Chiesi Farmaceutici SpA
Jun 1, 2026 09:05 AM Form SC 14D9/A KalVista Pharmaceuticals Filed by: KalVista Pharmaceuticals, Inc.
May 29, 2026 04:05 PM Form 4 KalVista Pharmaceuticals For: May 27 Filed by: Yea Christopher
May 28, 2026 07:00 AM KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema
May 27, 2026 05:19 PM Form 144 KalVista Pharmaceuticals Filed by: Yea Christopher
May 27, 2026 04:06 PM Form 4 KalVista Pharmaceuticals For: May 22 Filed by: Audhya Paul K.
May 27, 2026 04:06 PM Form 4 KalVista Pharmaceuticals For: May 22 Filed by: Yea Christopher
May 27, 2026 04:06 PM Form 4 KalVista Pharmaceuticals For: May 22 Filed by: Sweeny Nicole
May 26, 2026 07:35 PM Form 4 KalVista Pharmaceuticals For: May 21 Filed by: Palleiko Benjamin L
May 26, 2026 07:35 PM Form 4 KalVista Pharmaceuticals For: May 21 Filed by: Sweeny Nicole
View All Articles

Entities mentioned with KALV

View All Entities